Abstract
The new paradigm of multidimensional sleep health (‘sleep health’) offers both challenges and opportunities for sleep science. Buysse (2014) has described sleep health to be multidimensional, framed as positive attributes, operationalizable into composite measures of global sleep health, sensitive to upstream exposures, and consequential for downstream health. We highlight two paradigm-shifting effects of a multidimensional sleep health perspective. The first is the use of composite sleep metrics which i) enable quantification of population shifts in sleep health, ii) with possibly reduced measurement error, iii) greater statistical stability, and iv) reduced multiple-testing burdens. The second is that sleep dimensions do not occur in isolation, that is, they are commonly biologically or statistically dependent. These dependencies complicate hypothesis tests yet can be leveraged to inform scale construction, model interpretation, and inform targeted interventions. To illustrate these points, we i) extended Buysse’s Ru SATED model; ii) constructed a conceptual model of sleep health; and iii) showed exemplar analyses from the Multi-Ethnic Study of Atherosclerosis (n=735). Our findings support that sleep health is a distinctively useful paradigm to facilitate interpretation of a multitude of sleep dimensions. Nonetheless, the field of sleep health is still undergoing rapid development and is currently limited by: i) a lack of evidence-based cut-offs for defining optimal sleep health; ii) longitudinal data to define utility for predicting health outcomes; and iii) methodological research to inform how to best combine multiple dimensions for robust and reproducible composites.
Competing Interest Statement
JC, MW, TH, SB, and SR report funding from the NIH. SB reports consultant fees from Eisai, Inc, and Merck Sharpe & Dohme. The authors declare no other conflict.
Funding Statement
This research was supported by National Institute of Health grants 5T32HL007901-14, R35HL135818, R01HL098433; and by contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168 and N01-HC-95169 from the National Heart, Lung, and Blood Institute.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Primary data collection was approved by the Institutional Review Boards of MESA field centers. Publicly available, de-identified data were used in secondary analyses. Data are available at the National Sleep Research Resource (NSRR): https://sleepdata.org/
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
The secondary, de-identified data used in the manuscript are available at the National Sleep Research Resource (NSRR): https://sleepdata.org/
